ClinicalTrials.gg
TerminatedNCT01268540COASTUpdated Oct 5, 2026

Comparison of Aspheric Toric & Non-toric Aphakic Intraocular Lenses

An interventional study of FY-60AD and NHT15, NHT30, & NHT53 in Aphakia and Cataract, sponsored by Hoya Surgical Optics, Inc.. Terminated at 6 sites in United States. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2026-10-05.

Sponsored by Hoya Surgical Optics, Inc. · Not applicable, Interventional, and Treatment

How we know

Why this study was terminated
Rotational instability observed.
Updated Oct 5, 2026Now TerminatedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
235
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 29 studies in Aphakia with a site in United States — 2 open to participants now, 2 under way, none of them phase 3. Aphakia · United States.

Enrollment
9th of 23
235 · median 155
Started
2010
with 2 others
No phase
21 of 29
1 open now
Registered
5th of 29
by date
Lead sponsor
3 of 29
Hoya Surgical Optics, Inc.

Among the 29 studies in Aphakia with a site in United States, this one is the 9th largest by enrollment of the 23 interventional ones that give a count, is one of 3 that started in 2010, is one of 21 with no phase, and was the 5th registered.

Aphakia

69 studies on the registry are indexed under Aphakia; 6 are open to participants now.

Browse Aphakia studies →

Open to participants now

2 of the 29 studies in Aphakia with a site in United States are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 6 Aphakia studies recruiting now, 4 set no upper age limit and none stop at 75 or younger; none take children under 18; 1 takes healthy volunteers.

This study: 50 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 29 studies in Aphakia with a site in United States, or all of them as a file.
02

Study summary

The purpose of this multi-center clinical trial is to determine the safety and efficacy of the HSO Toric IOLs for the correction of aphakia and reduction of pre-existing refractive astigmatism.

03

Conditions studied

  • Aphakia
  • Cataract

Browse trials for

Keywords

  • intraocular lens
  • IOL
  • cataract
  • refractive astigmatism
  • Aspheric
  • Toric
  • Hoya
  • Surgical
  • Optics
  • visual acuity
04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Have been diagnosed with cataract for which phacoemulsification extraction and posterior chamber IOL implantation is indicated
  • Have at least one eye that meets the ranges of pre-operative corneal cylinder as specified by this study's guidelines, i.e. corneal cylinder of at least 1.0 D (after accounting for changes in corneal cylinder due to the incision)
  • Have potential Best Corrected Visual Acuity of 20/30 or better after implantation of a study lens
  • Have clear intraocular media other than cataract
  • Have preoperative Best Corrected Visual Acuity equal to 20/40 or worse, with or without a glare source

Exclusion criteria

Exclusion Criteria:

  • Have atonic pupils or physiologically small pupils in either eye (unable to dilate to at least 4 mm)
  • Have irregular astigmatism in the operative eye, or refractive cylinder resulting only from lenticular astigmatism in the operative eye
  • Have corneal pathology potentially affecting corneal topography, or other corneal abnormalities that do or are expected to reduce best corrected visual acuity in the operative eye during the study period
  • Have undergone previous refractive corneal surgery in the operative eye
  • Have been diagnosed with any degenerative retinal disorders (e.g. soft drusen, macular degeneration or other progressive retinal disorders) in the operative eye that are predicted to cause future visual acuity losses to a level of 20/30 or worse during the postoperative follow-up time requirements of this study

Eligibility criteria not complete. Contact Hoya Surgical Optics, Inc. for more information.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
235 participants (actual)

Study arms

  • Experimental
    NHT15

    Aspheric Toric Intraocular Lens Models NHT15

    Device: NHT15, NHT30, & NHT53

  • Active comparator
    FY-60AD

    Aspheric Non-toric Intraocular Lens: Model FY-60AD

    Device: FY-60AD

  • Experimental
    NHT30

    Aspheric Toric Intraocular Lens Model NHT30

    Device: NHT15, NHT30, & NHT53

  • Experimental
    NHT53

    Aspheric Toric Intraocular Lens Models NHT53

    Device: NHT15, NHT30, & NHT53

Interventions

  • DeviceFY-60AD

    Phacoemulsification cataract extraction followed by implantation of an aspheric non-toric intraocular lens: Model FY-60AD.

  • DeviceNHT15, NHT30, & NHT53

    Phacoemulsification cataract extraction followed by implantation of an aspheric toric intraocular lens: Model NHT15, NHT30, or NHT53.

06

What researchers measure

Primary outcomes

  1. percent reduction of absolute cylinder

    Time frame: up to 14 months

Secondary outcomes

  1. Lens rotation or misalignment and patient satisfaction

    Time frame: up to 14 months

07

Study locations

6 sites
  • Contact Hoya Surgical Optics, Inc. for Trial Locations
    Chino Hills, California 91709, United States
  • Shepard Eye Center
    Santa Maria, California 93454, United States
  • Mid-Florida Eye Center
    Mt. Dora, Florida 32757, United States
  • Grosinger, Spigelman & Grey,
    Bloomfield Hills, Michigan 48302, United States
  • Silverstein Eye Conters
    Dansas City, Missouri 64133, United States
  • Cleveland Eye Clinic
    Brecksville, Ohio 44141, United States
08

Timeline

1 registry update since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Dec 2010, a primary completion of Jun 2014 and a completion of Jun 2014. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 29, 2010
First posted
Dec 31, 2010
Start
Dec 2010
Primary completionActual
Jun 2014
CompletionActual
Jun 2014
Last update
Oct 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Completed→Terminated Rotational instability observed.
changed Oct 5, 2026
Show all 1 update
  1. Oct 5, 2026
    Completed→Terminated
    Why stopped Rotational instability observed.
    + 2 other changes: site details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT01268540
Lead sponsor
Hoya Surgical Optics, Inc.
Responsible party
Sponsor
First posted
Dec 31, 2010
Start date
Dec 2010
Primary completion
Jun 2014
Completion
Jun 2014
Last update
Oct 5, 2026

Study contacts

Kees den Besten
study director · Hoya Surgical Optics, Inc.

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Feb 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion